Search results for "SECR"

showing 10 items of 1169 documents

O1‐11‐06: Presenilin is the molecular target of both acidic and non‐acidic gamma‐secretase modulators

2012

Psychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceBiochemistryEpidemiologyChemistryHealth PolicyMolecular targetsNeurology (clinical)Geriatrics and GerontologyGamma secretasePresenilinAlzheimer's & Dementia
researchProduct

O1‐06‐07: Misprocessing of Multiple Transmembrane Substrates Reveals Gamma‐Secretase Dysfunction in Both Familial and Sporadic Alzheimer's Diseases

2009

Psychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceEpidemiologyHealth PolicyCancer researchNeurology (clinical)Geriatrics and GerontologyBiologyTransmembrane proteinGamma secretaseAlzheimer's & Dementia
researchProduct

P3‐344: γ‐secretase‐dependent APP processing occurs either at the plasma membrane or in the endocytic compartments independent of the APP wild‐type o…

2008

Psychiatry and Mental healthCellular and Molecular NeuroscienceMembraneDevelopmental NeuroscienceEpidemiologyChemistryHealth PolicyEndocytic cycleWild typeNeurology (clinical)γ secretaseGeriatrics and GerontologyCell biologyAlzheimer's & Dementia
researchProduct

P4–256: PACAP peptides as new α–secretase activators

2006

Psychiatry and Mental healthCellular and Molecular Neuroscienceα secretaseDevelopmental NeuroscienceBiochemistryEpidemiologyHealth PolicyNeurology (clinical)Geriatrics and GerontologyAlzheimer's & Dementia
researchProduct

Improved Magic Ink Signatures Using Hints

1999

We introduce two improvements to the recently proposed so called magic ink DSS signatures. A first improvement is that we reduce the overhead for tracing without noticeably increasing any other cost. The tracing cost is linear in the number of generated signatures in the original proposal; our improved version reduces this to a logarithmic cost in the common case. A second improvement is that we introduce a method for determining whether forged currency is in circulation, without affecting the privacy of honest users. Our improvements rely on our introducing a so called hint value. This is an encryption of the signature transcript received, submitted by the signature receiver. Part of the p…

Public-key cryptographyTheoretical computer sciencebusiness.industryComputer scienceMagic (programming)PlaintextCryptographyEncryptionbusinessAlgorithmSecret sharing
researchProduct

Soot-exposed mononuclear cells increase inflammatory cytokine mRNA expression and protein secretion in cocultured bronchial epithelial cells.

2000

<i>Background:</i> Soot particles are air pollutants capable of inducing airway and lung parenchymal injury. Mononuclear and bronchial epithelial cells are central to the maintenance of homeostasis and inflammation in the airways. <i>Objectives:</i> The aim of this study was to evaluate the contribution of mononuclear cells to the release of inflammatory mediators by bronchial epithelial cells. <i>Methods:</i> To model the in vivo situation, an in vitro system of cocultured blood monocytes and BEAS-2B cells was established in a transwell system. Blood monocytes were exposed to soot particles (FR 101) at concentrations of up to 100 μg/10<sup>6</su…

Pulmonary and Respiratory MedicineAdultMaleInflammationBronchiEnzyme-Linked Immunosorbent AssayBiologycomplex mixturesPeripheral blood mononuclear cellSensitivity and SpecificityMonocytesAir pollutantsParenchymamedicineHumansRNA MessengerSoot particlesCells CulturedAir PollutantsLungInterleukin-6Reverse Transcriptase Polymerase Chain ReactionInterleukin-8Epithelial CellsBlood Proteinsrespiratory systemCarbonCoculture Techniquesrespiratory tract diseasesCell biologymedicine.anatomical_structureSecretory proteinCytokinesCytokine mrnaFemalemedicine.symptomInflammation MediatorsRespiration; international review of thoracic diseases
researchProduct

Mucus and MUC in asthma.

2005

Asthma is characterized by chronic airway inflammation and a mucus hypersecretory phenotype comprising excess mucus secretion, goblet cell hyperplasia and submucosal gland hypertrophy. This augmented mucus secretion has been relatively undervalued in asthma compared with airway inflammation. However, mucus plugging contributes to airflow limitation and airway hyperresponsiveness, and to morbidity and mortality in asthma. We review recent contributions to this field and therapeutic avenues to control mucus hypersecretion.A distinct mucus hypersecretory phenotype may present in asthma. Overexpression of MUC5AC, MUC5B and MUC2 have been described in asthma secretions, but identification of def…

Pulmonary and Respiratory MedicineGoblet cell hyperplasiabusiness.industryMucinMucinsRespiratory Mucosarespiratory systemmedicine.diseaseMucusPhenotypeAsthmarespiratory tract diseasesMuscle hypertrophyMucusfluids and secretionsPhenotypeImmunologyChronic DiseaseMedicineHumansSecretionbusinessAirwayAsthmaCurrent opinion in pulmonary medicine
researchProduct

Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis.

1992

An activation of T-cells that is restricted to the lung has been demonstrated in pulmonary sarcoidosis. The role of blood monocytes (MO) and alveolar macrophages (AM) in this concept of compartmentalized inflammation has not yet been evaluated. In order to elucidate this question, we measured the release of tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) by peripheral blood mononuclear cells (PBMNC) and AM in 43 patients with sarcoidosis (32 with active, 11 with inactive disease) without therapy and correlated the spontaneous monokine release to parameters of the T-cell alveolitis and the course of the disease. TNF alpha as well as IL-1 were spontaneously released by AM of …

Pulmonary and Respiratory MedicineInterleukin 2Lung Diseasesmedicine.medical_specialtyTime FactorsSarcoidosisLung Diseases/metabolism610 MedizinInflammationSarcoidosis/metabolismLymphocyte ActivationMacrophages Alveolar/secretionPeripheral blood mononuclear cellMonocytesInterleukin-1/secretionInternal medicineMacrophages AlveolarmedicineMacrophageHumansddc:610Receptors Interleukin-2/metabolismTumor Necrosis Factor-alpha/secretionbusiness.industryTumor Necrosis Factor-alphaMonocyteLeukocytes Mononuclear/secretionMonocytes/immunologyReceptors Interleukin-2Macrophage ActivationMonokinemedicine.anatomical_structureEndocrinologyImmunologyAlveolar macrophageLeukocytes MononuclearInterleukin-2Tumor necrosis factor alphamedicine.symptomInterleukin-2/secretionbusinessmedicine.drugInterleukin-1The American review of respiratory disease
researchProduct

Persistent Tachypnea of Infancy. Usual and Aberrant.

2016

Persistent tachypnea of infancy (PTI) is a specific clinical entity of undefined etiology comprising the two diseases neuroendocrine cell hyperplasia of infancy (NEHI) and pulmonary interstitial glycogenosis. The outcome of typical NEHI is favorable. The outcome may be different for patients without a typical NEHI presentation, and thus a lung biopsy to differentiate the diseases is indicated.To determine whether infants with the characteristic clinical presentation and computed tomographic (CT) imaging of NEHI (referred to as "usual PTI") have long-term outcome and biopsy findings similar to those of infants with an aberrant presentation and/or with additional localized minor CT findings (…

Pulmonary and Respiratory MedicineMalePathologymedicine.medical_specialtyBiopsyLung biopsyCritical Care and Intensive Care MedicineTachypneaCohort Studies03 medical and health sciences0302 clinical medicineNeuroendocrine Cells030225 pediatricsBiopsymedicineHumansMedical historyChildLungRetrospective StudiesTachypneaLungHyperplasiamedicine.diagnostic_testbusiness.industryInfant NewbornInfantRetrospective cohort studyGlycogen Storage DiseaseNeurosecretory Systemsmedicine.anatomical_structure030228 respiratory systemChild PreschoolEtiologyFemaleRadiologymedicine.symptombusinessLung Diseases InterstitialTomography X-Ray ComputedCohort studyFollow-Up StudiesAmerican journal of respiratory and critical care medicine
researchProduct

Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.

2012

We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (GSMs) with a unique pharmacological profile. Our strategy included (i) virtual screening through application of a recently developed protocol (PhAST), (ii) synthetic chemistry to discover structure–activity relationships, and (iii) detailed in vitro pharmacological characterization. GSMs are promising agents for treatment or prevention of Alzheimer’s disease. They modulate the γ-secretase product spectrum (i.e., amyloid-β (Aβ) peptides of different length) and induce a shift from toxic Aβ42 to shorter Aβ species such as Aβ38 with no or minimal effect on the overall rate of γ-secretase cleavag…

PyridinesPyridonesMolecular Sequence DataPeptideComputational biologyCHO CellsBiochemistryStructure-Activity RelationshipAlzheimer DiseaseCricetinaeAnimalsHumansγ secretaseAmino Acid Sequencechemistry.chemical_classificationVirtual screeningActivity profileAmyloid beta-PeptidesChemistryGeneral MedicineIntegrated approachIn vitroMinimal effectDrug DesignMolecular MedicineAmyloid Precursor Protein SecretasesACS chemical biology
researchProduct